BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37540889)

  • 41. Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    de Krijger M; Carvalho B; Rausch C; Bolijn AS; Delis-van Diemen PM; Tijssen M; van Engeland M; Mostafavi N; Bogie RMM; Dekker E; Masclee AAM; Verheij J; Meijer GA; Ponsioen CY
    Inflamm Bowel Dis; 2022 Sep; 28(9):1309-1320. PubMed ID: 35554535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.
    Åberg F; Abdulle A; Mäkelä A; Nissinen M
    Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
    Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
    Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The microbiota and the gut-liver axis in primary sclerosing cholangitis.
    Hov JR; Karlsen TH
    Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):135-154. PubMed ID: 36352157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Bajer L; Wohl P; Drastich P
    Vnitr Lek; 2018; 64(6):659-664. PubMed ID: 30223664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
    Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
    Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease.
    Sayed A; Assis DN; Silveira MG; Deng Y; Ciarleglio M; Gaidos JKJ; Proctor DD; Al-Bawardy B
    Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):270-274. PubMed ID: 36708297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Loftus EV; Harewood GC; Loftus CG; Tremaine WJ; Harmsen WS; Zinsmeister AR; Jewell DA; Sandborn WJ
    Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
    van Munster KN; Bergquist A; Ponsioen CY
    J Hepatol; 2024 Jan; 80(1):155-168. PubMed ID: 37940453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.
    Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP
    Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.
    Okada H; Mizuno M; Yamamoto K; Tsuji T
    Acta Med Okayama; 1996 Oct; 50(5):227-35. PubMed ID: 8914675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Silvain C; Zeevi A; Saidman S; Duquesnoy RJ; Van Thiel DH
    Hepatogastroenterology; 1995 Jul; 42(3):250-8. PubMed ID: 7590574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output.
    Dyson JK; Elsharkawy AM; Lamb CA; Al-Rifai A; Newton JL; Jones DE; Hudson M
    Liver Int; 2015 May; 35(5):1633-41. PubMed ID: 25363895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
    Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
    Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
    Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
    Hole MJ; Jørgensen KK; Holm K; Braadland PR; Meyer-Myklestad MH; Medhus AW; Reikvam DH; Götz A; Grzyb K; Boberg KM; Karlsen TH; Kummen M; Hov JR
    Hepatology; 2023 Mar; 77(3):715-728. PubMed ID: 36056902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II.
    Rossen NG; Fuentes S; Boonstra K; D'Haens GR; Heilig HG; Zoetendal EG; de Vos WM; Ponsioen CY
    J Crohns Colitis; 2015 Apr; 9(4):342-8. PubMed ID: 25547975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.